Cardinal Health Org Chart & Sales Intelligence blog

Cardinal Health, Inc.
7000 Cardinal Place
Dublin, OH 43017
United States
Phone: (614) 757-5000
Website

Ticker Symbol: (NYSE: CAH)
Industry Sector: Healthcare - Medical Distribution
Full Time Employees: 46,500
CEO: Jason M. Hollar CEO & Director

Cardinal Health is ranked #15 on the 2022 Fortune 500 list

Cardinal Health on Social Media
Facebook | Twitter | LinkedIn | Youtube

What do the Cardinal Health Org Charts look like?

PREVIEW

DOWNLOAD THE CARDINAL HEALTH ORG CHART & SALES INTELLIGENCE REPORT TO SEE ALL 10 ORG CHARTS


Who are the decision-makers at Cardinal Health?

Who serves on Cardinal Health’s Board of Directors?

DOWNLOAD THE CARDINAL HEALTH ORG CHART & SALES INTELLIGENCE REPORT TO SEE MORE CONTACT INFORMATION

Where is Cardinal Health investing in their business?

PREVIEW

Cardinal Health CIO Michelle Greene on simplifying transformation
Dec 2022

Recently, I had the pleasure of speaking with Michelle Greene, who was promoted from SVP of EIT of Cardinal Health’s pharmaceutical segment to CIO last August. As technology chief, Greene is now charged with leading IT teams to help the Dublin, Ohio-based distributor and manufacturer of medical and laboratory products innovate new ways to evolve healthcare delivery. Central to that effort is structuring her IT organization to better partner with the business. Just three months into her tenure, Greene is already having an impact reorganizing IT — from application support to data analytics — for business impact.
Martha Heller: How do you define business transformation at Cardinal Health?

Michelle Greene: Business transformation at Cardinal Health is all about moving faster and being more agile to improve the experience of our customers. For example, we are advancing our digital capabilities to enable our customers across healthcare to seamlessly place, receive, and track orders more quickly. We all throw out this word “transformation” which seems like such a huge deal, but really, it is just about creating change. My goal is to simplify “transformation” into a clear strategy for achieving an end game. Right now, developing digital and commercial solutions for businesses across the company and our customers are key to our strategy. We are leveraging the power of data and analytics, artificial intelligence, automation, and more to enhance our products and services, internally and externally. But to be successful, we need to be in partnership with our business leaders and guide them along their technology journey. Too often in my IT leadership career, I felt like we were doing things to the business, instead of partnering with them.
How do you ensure IT has a strong partnership with the business?
In our new model, we will have technology leaders responsible for partnering with our pharma division, our medical division, and our corporate functions. Previously, the technology organizations in each division primarily operated separately, which led to siloed work with our heads down in our own space. My plan is for us to reimagine how our teams work together by simplifying our structure so we can operate as one organization and create seamless, cohesive experiences.

Martha Heller: What are the attributes you look for when filling those business-partner roles?

Michelle Greene: I look for people who are forward-thinking and have a strong ability to collaborate, both with their business partners and across the entire technology organization. I need people who can understand a problem and then point our technology teams in the right direction. Their job is not to solve problems themselves, but to define the strategy, get the right team on board, and help us focus on simplification. But, in order for the IT business partner roles to be successful, we need to centralize our foundational enterprise capabilities. For example, our SAP teams were previously spread out across the organization and typically worked separately unless there was a common issue. In our new model, we created an SAP center of excellence (CoE) that serves all parts of the business while also creating opportunities for best practice sharing, learning, career pathing, and better resource planning and deployment.

Read the full interview


Cardinal Health Names Aaron Alt Chief Financial Officer
Dec 2022

Cardinal Health (NYSE: CAH) and its board of directors announced today that Aaron Alt will become the company's new chief financial officer (CFO). Alt will succeed interim CFO, Trish English and will report to CEO, Jason Hollar, as a member of the company's Executive Committee effective Feb. 10. In his capacity as CFO, Alt will lead financial activities across the enterprise, including Financial Strategy, Capital Deployment, Treasury, Tax, Investor Relations, Accounting, and Reporting. Additionally, he will lead the Corporate Development team. "We're pleased to welcome Aaron as the new CFO of Cardinal Health," said Jason Hollar, CEO of Cardinal Health. "He's an exceptional talent with a breadth of experience across complex organizations that will position him well for this critical companywide role. I'd also like to thank Trish for her contributions as interim CFO and her commitment to help with this transition."
Alt most recently served as EVP and CFO for Sysco Corporation, the leading global foodservice distribution company. In this role, he drove significant improvements to the balance sheet and underlying profitability of Sysco. Prior to Sysco, Alt was SVP and CFO for Sally Beauty Holdings, an international specialty retailer and wholesale distributor of professional beauty supplies. He has also held senior executive roles in Finance, Operations and Grocery Transformation at Target Corporation. Prior to joining Target, he held senior-level Finance and Operations positions with Sara Lee Corporation. Aaron holds an M.B.A. from the J.L. Kellogg School of Management at Northwestern University, a J.D. from Harvard Law School and a B.A. in History and Political Science from Northwestern University.
Source


Cardinal Health Pilots Supply Chain Solution for Hospital at Home
Nov 2022

Cardinal Health has created a supply chain solution tailored to support the burgeoning hospital-at-home movement. Dublin, Ohio-based Cardinal’s Velocare is described as a supply chain network and last-mile fulfillment solution capable of reaching patients in one to two hours with critical products and services required for hospital-level care at home. To start, Cardinal Health at-Home Solutions is supporting a Medically Home health system customer pilot with Velocare, collectively enabling scaled, high-acuity care in the home. (In January 2022, Boston-based Medically Home announced that Cardinal Health was one of its investors.) Cardinal said Velocare brings together its capabilities through a combined offering intended for health systems, payers, digital health companies, telehealth providers and other entities moving high-acuity care to the home. Legacy Cardinal Health capabilities include global logistics and distribution expertise, management of a large network of suppliers and vendors, and access to a wide range of home-based care providers. The pilot with Medically Home will test the use of new technology, new order handling processes, small-format depots and short-haul delivery vehicles.
"We're excited to further expand our at-Home Solutions supply chain and logistics excellence to now reach patients receiving hospital-level care at home," said Rob Schlissberg, president, at-Home Solutions, in a statement. "With their mission of putting the patient at the center of care, combined with their differentiated supply chain network, Medically Home leads the way in bringing the hospital home. Our collaboration is driving scale and efficiency, and ultimately provides positive patient outcomes." The Velocare pilot includes real-time evaluation of the technology, service levels, effectiveness, patient experiences, plus consideration for future growth in new markets. "The ability to further scale the delivery of goods to the home will advance the rapidly growing hospital-at-home market, driving scale and efficiency for Medically Home's high-acuity care model," said Rami Karjian, CEO of Medically Home, in a statement. "The complexity of supply chain logistics is one of the significant barriers to health systems providing hospital-at-home care to their patients. This collaboration with Cardinal Health further enables the transformation of the delivery of patient care, which is at the heart of everything we do."
Source

DOWNLOAD THE CARDINAL HEALTH ORG CHART & SALES INTELLIGENCE REPORT TO SEE MORE ACTIONABLE SALES TRIGGER EVENTS

What are Cardinal Health executives saying about business performance?

Cardinal Health, Inc. (CAH) Q1 2023 Earnings Call Highlights
November 4, 2022

Executives in Attendance

• Kevin Moran, Vice President of Investor Relations
• Jason Hollar, Chief Executive Officer
• Trish English, Interim Chief Financial Officer

Comments from Jason Hollar - Chief Executive Officer:

"Overall, our performance in the first-quarter demonstrated continued stable fundamentals in our largest business, and tangible progress in Medical."

"In Pharma, we tracked slightly ahead of our expectations, as we delivered growth while managing industry-wide inflationary headwinds. We are encouraged by the ongoing stability in prescription volumes and strong performance of our generics program."

"In Medical, the quarter’s results were also a little better than expectations we announced in September. While I am pleased with our team’s efforts in the quarter to achieve these results, there is more work to be done to drive better, more predictable financial performance in-line with the underlying potential of this business. We are highly-focused on executing our Medical Improvement Plan initiatives, which I will cover in greater detail later in my remarks."

"Across the company, our team is operating with urgency to drive our businesses forward and committed to creating value for our shareholders."


Comments from Trish English - Interim Chief Financial Officer:

"First quarter total company revenue increased 13%, driven by Pharma segment sales growth."

"Gross margin decreased 2% to $1.6 billion due to net inflationary impacts in Medical and one month’s impact of the Cordis divestiture, partially offset by our Pharma generics program performance."

"Consolidated SG&A increased 7%, reflecting inflationary supply chain costs and other operating expenses such as higher costs to support Pharma sales growth. This increase was partially offset by the Cordis divestiture and benefits from enterprise-wide cost savings initiatives."

"Operating earnings decreased 20% to $423 million, reflecting the decline in Medical segment profit, primarily due to net inflationary impacts, and partially offset by growth in Pharma segment profit."

"Now, moving below the line, Interest and Other decreased 25% to $27 million dollars, primarily driven by increased interest income from cash and equivalents. As a reminder, our debt is largely fixed rate, resulting in a net benefit from rising interest rates."

"Our first quarter Effective Tax Rate finished at 16.9%, approximately 7 percentage points lower than prior year due to certain favorable discrete items."

"Diluted weighted average shares were $273 million, 6% lower than a year ago due to share repurchases. We are focused on balanced, disciplined, and shareholder-friendly capital deployment and in mid-September, we initiated a $1 billion dollar Accelerated Share Repurchase program that we expect to complete in the second quarter."

"We generated first quarter operating cash flow of approximately $25 million dollars. This includes total litigation payments of approximately $390 million dollars, primarily consisting of the second payment under the national opioid settlement. Adjusted free cash flow in our first quarter was $342 million dollars."

"First-quarter revenue increased 15% to $46 billion dollars, driven by branded Pharmaceutical sales growth from existing and net new Pharmaceutical Distribution and Specialty customers."

"Pharma segment profit increased 6% to $431 million dollars, driven by generics program performance and a higher contribution from brand and specialty products, partially offset by inflationary supply chain costs."

"During the quarter, we were pleased to see strong execution and continued consistent market dynamics in our generics program, including Red Oak."

Source


What do the Cardinal Health financials look like?

DOWNLOAD THE CARDINAL HEALTH ORG CHART & SALES INTELLIGENCE REPORT TO SEE THE COMPLETE FINANCIAL INSIGHTS & ANALYSIS


Where is Cardinal Health utilizing cloud technologies?

Senior Data Engineer
Location: Ohio
The role is part of Advanced Analytics team that leverages emerging cloud technologies to build Data Platforms and Analytics Solutions including Machine Learning activities supporting Outcomes Business. Team leverages agile DevOps (DataOps, MLOps) practices, and automation to enable speed, quality, and produce insights that contribute to patient outcomes. Help define and implement cloud-based infrastructure for Data Lakes, Analytics and Machine Learning initiatives. Primary focus is to architect, implement and operationalize large-scale Data and Analytics solutions leveraging one or more AWS Cloud technologies like RedShift, Data Glue, Lake Formation, and SageMaker. As a primary subject matter expert, provide consultation services and guiding various build and operations teams to productionize Data and Analytics workloads. Design, develop and maintain data pipelines from a verity of sources to populate data lakes, data warehouses, data transformation rules, and data modeling capabilities. Define how data analytics and ML/AI capabilities will apply to business needs and result in dependable business solutions. Responsible for data ingestion to cloud data lakes and data warehouses, quality control, metadata management and engineering development for data science teams.
Technologies in use: Data Warehouse/Data Lake, OLAP databases such as AWS Redshift or Snowflake, BI Reporting and Data Discovery tools, Python ETL applications, Git for version control and pytest for automated testing, Apache Airflow, Python libraries such as pandas and Jupyter Notebooks, CI/CD tool such as Concourse or Jenkins, Tableau, Cloud Native Technologies


Full Stack Java and Angular Developer
Locations: FL, OH, SC, GA, NC, MI, PA, VA
LRCQ IT enables technology solutions for the Legal, Regulatory, Compliance, and Quality teams at Cardinal Health. This business team is accountable for anti-diversion, regulatory reporting, recalls administration, quality, and legal processes throughout the enterprise. The LRCQ IT technology suite includes multiple cloud-native, legacy, and commercial off-the-shelf and vendor supported applications. The team is actively implementing a multi-year technology evolution plan and are building from scratch or enhancing highly integrated applications that are micro-service, event, and API-driven. These applications are built on Angular, Java Spring Boot, Cloud SQL, Kafka, BigQuery, Google Cloud Functions, Apigee, Concourse, SonarQube, VeraCode, and Git technologies.
Technologies in use: Java Spring Boot, Angular, Micro Service/JSON Rest Service, JPA, SQL, GIT or equivalent Version Management Tool, XML, Apigee, Java Script/jQuery, CSS, PCF, Concourse/Jenkins Pipeline, Google Cloud Platform, PostGRE SQL


Scrum Master (ATF)
Location: Ohio
Information Technology oversees the effective development, delivery, and operation of computing and information services. This function anticipates, plans, and delivers Information Technology solutions and strategies that enable operations and drive business value. Agile is responsible for leading, planning and implementing new ways of working for our business development teams centered on agile and DevSecOps practices. This includes creating, training and coaching of standard work practices and learning, implementing and reinforcing these practices toward the goal of greater business agility. Guiding the team and organization on how to adopt agile practices and values to delight customers. Coaching team in self-organization, cross-functionality and Team Based Solutioning (TBS). Coaching team and stakeholders to understand and embrace empirical product development. Protecting the autonomy of the team, allowing for self-organization without outside influence. Removing impediments or guiding the team to remove impediments by finding the right personnel to remove the impediment. Supporting and educating the Product Owner, especially on value management practices for effective Product Backlog refinement & prioritization practices.
Technologies in use: Microsoft Office products, ex Jira, Azure DevOps